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Abstract. 
 
Membrane scaffolding complexes are key 
features of many cell types, serving as specialized links 
between the extracellular matrix and the actin cytoskel-
eton. An important scaffold in skeletal muscle is the 
dystrophin-associated protein complex. One of the pro-
teins bound directly to dystrophin is syntrophin, a mod-
ular protein comprised entirely of interaction motifs, in-
cluding PDZ (protein domain named for PSD-95, discs 
large, ZO-1) and pleckstrin homology (PH) domains. In 
skeletal muscle, the syntrophin PDZ domain recruits 
sodium channels and signaling molecules, such as neu-
ronal nitric oxide synthase, to the dystrophin complex. 
In epithelia, we identiﬁed a variation of the dystrophin 
complex, in which syntrophin, and the dystrophin ho-
mologues, utrophin and dystrobrevin, are restricted to 
the basolateral membrane. We used exogenously ex-
pressed green ﬂuorescent protein (GFP)-tagged fusion 
proteins to determine which domains of syntrophin are 
responsible for its polarized localization. GFP-tagged 
full-length syntrophin targeted to the basolateral mem-
brane, but individual domains remained in the cyto-
plasm. In contrast, the second PH domain tandemly 
linked to a highly conserved, COOH-terminal region 
was sufﬁcient for basolateral membrane targeting and 
association with utrophin. The results suggest an inter-
action between syntrophin and utrophin that leaves the 
PDZ domain of syntrophin available to recruit addi-
tional proteins to the epithelial basolateral membrane. 
The assembly of multiprotein signaling complexes at 
sites of membrane specialization may be a widespread 
function of dystrophin-related protein complexes.
Key words: syntrophin • utrophin • dystrobrevin • 
Madin-Darby canine kidney • green ﬂuorescent protein
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 cytoskeleton plays an important role in estab-
lishing structural and functional specializations at
sites of cell–cell contact. For instance, at the post-
synaptic density, cytoskeletal proteins participate in a
complex that localizes receptors and ion channels for effi-
cient signal transduction (Cho et al., 1992; Kornau et al.,
1995; Kim et al., 1996; Dong et al., 1997; Srivastava et al.,
1998). In polarized epithelia, membrane specializations
form tight junctions (TJs)
 
1
 
 which separate the apical and
basolateral membranes, and function as barriers to diffu-
sion across the epithelium (Gumbiner, 1987). Proteins
such as ZO-1 are highly localized at the TJ (Stevenson et al.,
1986) where they are thought to anchor transmembrane
proteins, such as occludin (Furuse et al., 1994; Fanning
et al., 1998). Similar multiprotein complexes have been de-
scribed for the apical and basolateral membranes where
transmembrane proteins, such as the cystic fibrosis trans-
membrane conductance regulator, and the proteoglycan,
syndecan, are linked to the actin cytoskeleton (Cohen et
al., 1998; Short et al., 1998). Finally, in skeletal muscle, the
cytoskeletal protein, dystrophin, anchors transmembrane
and signaling proteins at the neuromuscular junction (Col-
ledge and Froehner, 1998). Although expressed in differ-
ent cell types, these complexes share the common ability
to serve as a scaffold on which transmembrane and periph-
eral membrane proteins assemble.
A scaffolding complex common to neurons, epithelia,
and muscle is the dystrophin-associated protein complex
(DAPC; Lidov et al., 1990; Kim et al., 1992; Ahn and
Kunkel, 1993; Ervasti and Campbell, 1993; Schmitz et al.,
1993; Montanaro et al., 1995; Durbeej et al., 1998). Dystro-
phin is a 427-kD flexible rod-like protein consisting of an
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Abbreviations used in this paper:
 
 DAPC, dystrophin-associated protein
complex; ECM, extracellular matrix; GFP, green fluorescent protein;
GFP-FL, GFP fused to NH
 
2
 
 terminus of full-length 
 
b
 
2-syntrophin; HB,
homogenization buffer; nNOS, neuronal nitric oxide synthase; PDZ, pro-
tein domain named for PSD-95, discs large, ZO-1; PH, pleckstrin homol-
ogy; SU, syntrophin unique; TJ, tight junction. 
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NH
 
2
 
-terminal actin binding domain, 24 spectrin-like re-
peats, a cysteine-rich region, and a COOH-terminal do-
main (Koenig et al., 1988; Koenig and Kunkel, 1990; Ahn
and Kunkel, 1993; Rybakaova et al., 1996). The DAPC has
been studied most extensively in skeletal muscle, where
mutations in the dystrophin gene result in the severe mus-
cle-wasting of Duchenne and Becker muscular dystrophies
(Straub and Campbell, 1997). Dystrophin belongs to a
large family of proteins, including short forms of dystro-
phin and the dystrophin homologues, utrophin, dystro-
phin-related protein 2 (DRP2), and 
 
a
 
- and 
 
b
 
-dystrobrevins
(Tinsley et al., 1992; Blake et al., 1996, 1998; Roberts et al.,
1996; Sadoulet-Puccio et al., 1996; Peters et al., 1997b;
Puca et al., 1998).
Two possible functions have been ascribed to dystro-
phin family members. First, dystrophin binds a trans-
membrane protein, 
 
b
 
-dystroglycan, which is linked to
extracellular laminin through 
 
a
 
-dystroglycan (Ibraghi-
mov-Beskrovnaya et al., 1992; Gee et al., 1993). Dystro-
phin also binds actin, thereby providing a link between the
extracellular matrix (ECM) and the cytoskeleton (Ahn and
Kunkel, 1993; Ervasti and Campbell, 1993; Rybakaova et
al., 1996). This structural role may protect muscle from the
shearing forces of contraction (Petrof et al., 1993; Pasternak
et al., 1995). In addition, the dystrophin complex has
emerged as a potential signaling complex, due in part to a
family of modular adapter proteins, the syntrophins. The
three isoforms of syntrophin (
 
a
 
1, 
 
b
 
1, and 
 
b
 
2) interact di-
rectly with dystrophin family members, are encoded by
separate genes, and consist primarily of protein–protein
interaction domains (Ahn et al., 1994, 1996; Adams et al.,
1995). Syntrophins have two pleckstrin homology (PH)
domains, which are often found in cytoskeletal or signaling
proteins where they mediate protein–protein or protein–
lipid interactions (Shaw, 1996). Syntrophins also contain a
single PDZ domain, named for the three proteins in which
they were first recognized (PSD-95, discs large, ZO-1).
PDZ domains bind specific sequences on the COOH-ter-
minal tails of ion channels and receptors, perhaps serving
to cluster these proteins at specialized sites (reviewed in
Sheng, 1996; Kornau et al., 1997). In addition, PDZ do-
mains form homo- or heterodimers (Brenman et al., 1996;
Srivastava et al., 1998; Xu et al., 1998). Using both mecha-
nisms, syntrophin PDZ domains bind the extreme COOH-
terminal tail of voltage-gated sodium channels (Gee et al.,
1998; Schultz et al., 1998), or the PDZ domain of neuro-
nal nitric oxide synthase (nNOS; Brenman et al., 1996),
thereby recruiting these signaling proteins to the dystro-
phin complex.
The DAPC is often concentrated at sites of membrane
specialization, such as central nervous system synapses
(Lidov et al., 1990; Kim et al., 1992; Schmitz et al., 1993;
Montanaro et al., 1995) and the neuromuscular junction
(Ohlendieck et al., 1991b; Bewick et al., 1992; Peters et
al., 1997a, 1998), where the complex may serve both struc-
tural and signaling functions. Interestingly, the precise
composition of proteins in the DAPC varies by cell type or
subcellular localization. For instance, at the crests of the
neuromuscular postjunctional folds, rapsyn and utrophin
are concentrated with nAChRs (Fertuck and Salpeter,
1974; Sealock et al., 1984; Ohlendieck et al., 1991b; Bewick
et al., 1992), while in the troughs of the folds dystrophin,
 
b
 
2-syntrophin, and voltage-gated sodium channels pre-
dominate (Flucher and Daniels, 1989; Kramarcy, N., and
R. Sealock, personal communication). In addition, forms
of 
 
a
 
-dystrobrevin generated by alternative splicing are dis-
tributed differentially at the neuromuscular junction (Ba-
lasubramian et al., 1998; Peters et al., 1998). Presumably,
the functional properties of the DAPC are determined by
its protein composition.
The expression of syntrophins, utrophin, and some dys-
trobrevin isoforms in tissues such as lung, kidney, testis,
and intestine (Khurana et al., 1990; Love et al., 1991; Ad-
ams et al., 1993; Blake et al., 1996; Peters et al., 1997a,b)
suggests that these proteins may also play a role in epithe-
lial tissues. Expression of dystroglycans in epithelia in vivo
(Durbeej et al., 1998) and the demonstration that antibod-
ies that block laminin binding to dystroglycan disrupt epi-
thelial cell differentiation (Durbeej et al., 1995) indicate
that the dystrophin complex may play a critical functional
role in epithelial cells. We have explored the localization
and targeting of the DAPC using the MDCK epithelial
cell line. Our data define a new variation of the DAPC
that may be involved in the generation or maintenance of
cell polarity and the formation of signaling complexes in
epithelia.
 
Materials and Methods
 
Antibodies
 
Antisyntrophin Antibodies.  
 
mAb SYN1351 recognizes all syntrophin iso-
forms (Froehner et al., 1987). Syntrophin isoform-specific polyclonal anti-
bodies SYN17 (
 
a
 
1-syntrophin), SYN28 (
 
b
 
2-syntrophin), and SYN37 (
 
b
 
1-
syntrophin; all used at 30 nM IgG) have been described previously (Peters
et al., 1997a).
 
Antiutrophin Antibody.  
 
mAb MANCHO-3 (a gift of G.E. Morris) is
described elsewhere (Nguyen et al., 1991; Morris et al., 1998).
 
Antidystrobrevin Antibodies.  
 
Antibody 13H1 (a gift of J.B. Cohen;
Carr et al., 1989) recognizes both 
 
a
 
- and 
 
b
 
-dystrobrevins (Peters et al.,
1997b).
 
Antidystrophin Antibodies.  
 
Antibody NCL-DYS2 (epitope in the COOH
terminus of dystrophin) is known to cross-react with the canine protein
(Novacastra). mAb 1808 raised against 
 
Torpedo
 
 dystrophin recognizes the
rod domain of dystrophin (Sealock et al., 1991).
 
Antidystroglycan Antibody.  
 
Monoclonal anti–
 
a
 
-dystroglycan antibody,
VIA4-1 (Upstate Biotechnology Inc.), is described elsewhere (Ohlendieck
et al., 1991a).
 
Other Antibodies.  
 
Monoclonal and polyclonal anti-GFP (green fluores-
cent protein) antibodies (Clontech Laboratories, Inc.), anti–
 
b
 
-catenin
(Santa Cruz Biotechnology), anti–ZO-1 (Zymed Labs, Inc.), and anti-
Na/K ATPase (Chemicon International, Inc.) were used according to
manufacturers’ specifications.
 
Transfections
 
The following mouse 
 
b
 
2-syntrophin constructs were subcloned using com-
mon restriction sites into pEGFPC2 expression vector (Clontech Labora-
tories, Inc.): full-length (FL; aa 1–520); PH1 (aa 1–94 and 175–288); PDZ
(aa 90–185); PH2 (aa 296–425); and syntrophin unique (SU; aa 421–520).
 
a
 
1-syntrophin PDZ (aa 75–171) and 
 
b
 
1-syntrophin PDZ (aa 105–200)
were also subcloned into the same vector. The PH2SU (aa 296–520) and
PH1PDZ (aa 1–288) constructs were amplified by PCR and were sub-
cloned using engineered restriction sites. All constructs were sequenced
before use. Type II MDCK cells were transfected using lipofectamine
(GIBCO BRL) according to manufacturer’s recommendations. After 10–
14 d of growth in selection medium (DME 
 
1
 
 5% FBS 
 
1
 
 400 
 
m
 
g/ml G418),
individual colonies were isolated and stable lines were established. Wild-
type MDCK cells were maintained in DME 
 
1
 
 5% FBS. 
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Immunofluorescence Analysis of MDCK Cells
 
Cells were grown to confluence on glass coverslips (5–7 d), fixed in 2%
paraformaldehyde for 15 min, and either analyzed for GFP expression im-
mediately, or prepared further for immunofluorescence. Cells were per-
meabilized for 15 min in PBS/0.5% Triton X-100, blocked in PBS/1% fish
gelatin/0.8% BSA for 30 min, and incubated with primary antibodies at
the appropriate dilution for 1 h at room temperature or overnight at 4
 
8
 
C.
After washing in PBS/0.5% Triton X-100, cells were incubated with Alexa
488–conjugated secondary antibody (Molecular Probes, Inc.) and either
Texas red–conjugated (Jackson ImmunoResearch Laboratories, Inc.) or
Alexa 594–conjugated (Molecular Probes, Inc.) secondary antibody for 1 h
at room temperature. Cells were washed with PBS/0.5% Triton X-100 and
mounted onto slides in glycerol with 
 
n
 
-propyl gallate to minimize fading
(Giloh and Sedat, 1982). Staining was analyzed using confocal microscopy
(Leica TCS-NT). Results were similar when MDCK cells were grown for
5–7 d on transwell filters (Corning Costar).
 
Coimmunoprecipitations
 
Wild-type or GFP-expressing MDCK cell lines were grown on 100-mm
plates for 5–7 d. Cells were rinsed in ice-cold homogenization buffer (HB;
10 mM sodium phosphate, 0.4 M NaCl, 5 mM EDTA, pH 7.8) and lysed
for 30 min on ice in HB/1% Triton X-100 (750 
 
m
 
l/plate) with protease in-
hibitors (2 mM PMSF, 1 
 
m
 
M bestatin, and 1 
 
m
 
g/ml each of aprotinin, leu-
peptin, antipain, and pepstatin A). Insoluble proteins were pelleted at
39,000 
 
g
 
 for 30 min. The soluble extracts were then incubated with 1 
 
m
 
g of
specific antibody or control IgG for 1 h at 4
 
8
 
C. Protein A– or G–agarose
(Sigma Chemical Co.; 25 
 
m
 
l of 50% slurry) was added and incubated over-
night at 4
 
8
 
C. Beads were washed extensively in HB containing 1 M NaCl/
1% Triton X-100. Proteins eluted in SDS sample buffer were separated by
SDS-PAGE and transferred to nitrocellulose for immunoblotting as de-
scribed previously (Peters et al., 1997a). In brief, after blocking in TBS/
0.1% Tween 20 (TBST) with 5% milk for 1 h at room temperature, nitro-
cellulose was incubated with primary antibody diluted in TBST/1% milk
for 1 h at room temperature. Blots were washed 3 times for 15 min each in
TBST, and were then incubated with an HRP-conjugated secondary anti-
body (Jackson ImmunoResearch Laboratories, Inc.) for 1 h at room tem-
perature. Blots were washed as before and signal was detected using en-
hanced chemiluminescence (Pierce Chemical Co.) and exposed to film.
Nitrocellulose blots were occasionally reprobed after stripping with strip-
ping buffer (Chemicon International, Inc.).
 
Results
 
Syntrophin, Utrophin, and Dystrobrevin Are Expressed 
in Polarized Epithelial Cells
 
Syntrophins are found in many tissues in which epithelia
are a major cell type, including lung and kidney (Adams et
al., 1993; Peters et al., 1997a). However, these tissues con-
tain a mixture of epithelial and nonepithelial cells. To
study the expression and distribution of syntrophins in po-
larized epithelial cells, we used MDCK cells. Expression
of components of the DAPC was determined by immuno-
blotting of Triton X-100 soluble and insoluble fractions
from MDCK cells. An mAb that recognizes all three syn-
trophin isoforms (SYN1351) detected a single band of 60
kD (the size expected for syntrophins; Fig. 1). Most of this
protein was found in the Triton X-100 soluble fraction.
Utrophin, a dystrophin homologue, was also found (Fig. 1)
and, like syntrophins, was detected primarily in the Triton
X-100 soluble fraction. Syntrophin and utrophin were also
found in two additional polarized epithelial cell lines:
HBE, a human bronchial epithelia cell line; and LLCPK, a
pig renal epithelia cell line (data not shown).
The expression of syntrophin isoforms differs among tis-
sue types. For instance, skeletal muscle contains all three
syntrophin isoforms, while 
 
b
 
1-syntrophin is the predomi-
nant form in liver (Peters et al., 1997a). To identify the
syntrophin isoforms expressed in polarized epithelia, sam-
ples enriched for syntrophins by immunoprecipitation
with SYN1351 were analyzed by immunoblotting with an-
tibodies specific for each of the three syntrophin isoforms.
 
b
 
2-Syntrophin was the only syntrophin isoform consis-
tently detected (Fig. 2), although in some experiments
small amounts of 
 
a
 
1-syntrophin were also found. Given its
abundance in the epithelial cell lines tested and in tissues
rich in epithelial cells, 
 
b
 
2-syntrophin appears to be the
predominant form of syntrophin in epithelia.
In skeletal muscle, syntrophins associate directly with
dystrophin family members (Kramarcy et al., 1994; Yang
et al., 1994; Ahn and Kunkel, 1995; Dwyer and Froehner,
1995; Ahn et al., 1996). This also appears to be the case in
MDCK cells. Utrophin and a form of dystrobrevin were
specifically enriched in SYN1351 preparations, but were
absent from control preparations (Fig. 2). These results in-
dicate that syntrophin, utrophin, and dystrobrevin exist in
a stable complex in polarized epithelial cells.
 
Syntrophin and Utrophin Are Expressed on the 
Basolateral Membrane of Polarized Epithelia
 
Polarized epithelial cells have two distinct membrane do-
mains that differ greatly in lipid and protein content (Si-
mons and Fuller, 1985; Rodriguez-Boulan and Nelson,
1989). To determine the localization of the syntrophin/
utrophin complex, we compared the distribution of syntro-
Figure 1. Syntrophins and utrophin are
expressed in MDCK cells. MDCK cells
were solubilized in HB containing 1%
Triton X-100. Equal volumes of Triton
X-100 soluble and insoluble fractions
were separated by SDS-PAGE and im-
munoblotted with panspecific syntro-
phin antibody SYN1351, antiutrophin,
anti–b-catenin, or anti–ZO-1 antibod-
ies. Syntrophin and utrophin are found
primarily in the Triton X-100 soluble
fraction. Positions of molecular mass
markers are shown in kD on the left.
Figure 2. b2-Syntrophin, utrophin, and
dystrobrevin exist in a stable complex
in MDCK cells. Triton X-100 soluble
fractions from MDCK cells were en-
riched for syntrophins by immunopre-
cipitation with SYN1351 (panspecific
syntrophin antibody) or mouse IgG as
a control. Enriched fractions were im-
munoblotted with antiutrophin, anti-
dystrobrevin, or antibodies specific for
each syntrophin isoform. b2-Syntro-
phin is the predominant isoform of syn-
trophin in MDCK cells and is found in
a stable complex with utrophin and a
form of dystrobrevin. 
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phin with ZO-1, 
 
b
 
-catenin, and Na/K ATPase, markers of
distinct membrane specializations in polarized MDCK
cells. The distribution of syntrophin (Fig. 3 A) was very
similar to that of Na/K ATPase, which is largely basolat-
eral. Syntrophin outlined the cell on its basal and lateral
surfaces, but was absent from the apical membrane.
The lateral membrane of polarized epithelial cells con-
tains two specialized structures, the TJ and the adherens
junction. The TJ is located at the intersection of the apical
and basolateral membrane, where it acts to regulate diffu-
sion across the epithelium and as a barrier between the
apical and basolateral membrane (reviewed in Gumbiner,
1987). The adherens junction is a cadherin-based special-
ization believed to be involved in adhesion of epithelial
cells (Gumbiner, 1996; reviewed in Yap et al., 1997). In ad-
dition to providing useful markers for subdomains within
the lateral membrane, the TJ and adherens junction are
key structures of epithelial cells where numerous PDZ-
containing proteins have been shown to be important
(Stevenson et al., 1986; Beatch et al., 1996; reviewed in
Kim, 1997; Mandai et al., 1999; Haskins et al., 1998; Izumi
et al., 1998; Satoh et al., 1998). Therefore, we were inter-
ested in the relationship between the syntrophin complex
and these junctions. 
 
b
 
-Catenin is found enriched at the ad-
herens junction and in a cytosolic pool (Hinck et al., 1994;
Nathke et al., 1994). As shown in Fig. 3 B, syntrophin and
 
b
 
-catenin are colocalized on the lateral membrane. Anti–
ZO-1 specifically labeled TJs (Stevenson et al., 1986), and
appeared to represent the upper limit of syntrophin ex-
pression (Fig. 3 C). The distribution of utrophin was indis-
tinguishable from that of syntrophin, having the same lim-
its of expression when double labeled with anti–ZO-1
antibodies (Fig. 3 D).
 
GFP-tagged 
 
b
 
2-Syntrophin Targets to the Basolateral 
Membrane of MDCK Cells
 
While PDZ-containing proteins have been shown to be
important at synapses and cell–cell junctions (reviewed in
Kim, 1997), only the targeting of Dlg/SAP97 (Lue et al.,
1996; Hough et al., 1997; Wu et al., 1998) and ZO-1 (Fan-
ning et al., 1998) has been studied extensively. As a first
step in determining which domains of syntrophin are re-
sponsible for its localization on the basolateral membrane,
we studied the distribution of exogenously expressed GFP
fusion proteins of syntrophin (Fig. 4). MDCK cells were
transfected with a plasmid encoding GFP fused to the NH
 
2
 
terminus of full-length 
 
b
 
2-syntrophin (GFP-FL) and mul-
tiple stable cell lines were established. GFP-FL was found
exclusively on the basolateral membrane, in a distribution
Figure 3. The syntrophin/utrophin complex is restricted to the basolateral membrane of polarized epithelia. MDCK cells were grown to
confluence on glass coverslips for immunofluorescence analysis. Staining was analyzed using confocal microscopy and is shown as XZ
scans. (A) Syntrophin is restricted to the basolateral membrane where it colocalizes with the largely basolateral protein, Na/K ATPase.
(B) Syntrophin colocalizes with the b-catenin on the lateral membrane. b-Catenin is also found in cytosolic pools. (C) Syntrophin distri-
bution extends up to, but not past, TJs (labeled by anti–ZO-1). (D) The distribution of utrophin is indistinguishable from that of syntro-
phin. Utrophin does not extend past TJs (labeled by anti–ZO-1). Bars, 10 mm. 
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indistinguishable from that of endogenous syntrophin
(Fig. 5 A). In contrast, GFP alone was found only in the
cytoplasm.
Syntrophins contain four distinct domains: two PH do-
mains, a PDZ domain, and an SU domain (Adams et al.,
1995; Ahn and Kunkel, 1996). Any of these domains could
be involved in targeting to the basolateral membrane.
Since PH domains in other proteins have been shown to be
capable of binding phospholipids (Shaw et al., 1996), the
PH domain(s) of syntrophin may recruit syntrophin to the
basolateral membrane through binding to specific types of
lipids. This model is especially attractive since the apical
and basolateral membranes differ in lipid content (Sim-
mons and Fuller, 1985; Rodriguez-Boulan and Nelson,
1989). Alternatively, the PDZ domain could direct syntro-
phin to the basolateral surface by binding a ligand that is
restricted to the basolateral membrane. This could be a
general mechanism by which PDZ-containing proteins are
recruited to specialized sites. Finally, the SU domain,
which is unrelated to any known protein domain, may be
responsible for targeting syntrophin to specific subcellular
compartments.
To examine these possibilities, we established stable
MDCK cell lines expressing individual 
 
b
 
2-syntrophin
domains fused with GFP (Fig. 4) and compared the dis-
tribution of the GFP fusion proteins with endogenous
syntrophin. The PH1, PDZ, PH2, and SU domains of 
 
b
 
2-
syntrophin all failed to accumulate at the basolateral
membrane (Fig. 5 B). The PDZ domains of 
 
a
 
1-syntrophin
and 
 
b
 
1-syntrophin also failed to target (data not shown).
Each individual domain was distributed diffusely through-
out the cell and was identical to the distribution of GFP
alone (Fig. 5 B). In the PH1 and PH2 cell lines, labeled
cells were very sparse. We counted 
 
.
 
200 positive cells in
three independent cell lines for each construct. In all cases,
the GFP-tagged domain was diffusely distributed through-
out the cell.
The failure of individual domains to localize preferen-
tially to the basolateral membrane may be due to their in-
ability to bind a partner, perhaps utrophin, which resides
on this membrane. The COOH-terminal 37 kD of 
 
b
 
1-syn-
trophin, consisting of part of the PH1 domain, along with
the PH2 and SU domains, is sufficient to bind to dystro-
phin family members in vitro (Ahn and Kunkel, 1995). In-
dividual domains of syntrophin may not retain their ability
to bind utrophin, and therefore cannot be recruited to or
retained at the basolateral membrane. To test this hypoth-
esis, we made two additional GFP constructs which con-
sisted of tandemly linked PH2 and SU domains (PH2SU),
or the linked PH1 and PDZ domains of 
 
b
 
2-syntrophin
(Fig. 4). In multiple stable cell lines, GFP-PH2SU was
found on the basolateral membrane (Fig. 5 C), in a distri-
bution indistinguishable from endogenous syntrophin or
expressed GFP-FL. In contrast, GFP-PH1PDZ failed to
accumulate at the basolateral membrane (Fig. 5 C), indi-
cating that the PH2SU construct is necessary and suffi-
cient for basolateral sorting. Recently, the targeting of
some GFP-tagged proteins was shown to be substratum
dependent (Moyer et al., 1998). However, we obtained
similar syntrophin domain targeting results whether trans-
fected MDCK cells were plated on glass coverslips or on
transwell filters (data not shown).
 
Syntrophin Domain Interactions with Utrophin
 
To test biochemically whether GFP-PH2SU retains the
ability to bind utrophin while individual syntrophin do-
mains and PH1PDZ do not, we immunoprecipitated each
GFP fusion protein and determined whether utrophin was
specifically coisolated. Detergent extracts from cell lines
expressing GFP, or fusion proteins of full-length 
 
b
 
2-
syntrophin, PH2SU, PH1PDZ, or individual syntrophin
domains were subjected to immunoprecipitation with
anti-GFP or control antibody. To confirm the size and ex-
pression level of each fusion protein, immunoprecipitates
were analyzed by immunoblotting with a monoclonal anti-
GFP antibody. Sample loadings were then adjusted to ob-
tain comparable amounts of each fusion protein (Fig. 6).
The top halves of the same blots were incubated with a
monoclonal antiutrophin antibody. As expected, utrophin
was specifically coimmunoprecipitated with GFP-FL, indi-
cating that fusion with GFP did not interfere with the in-
Figure 4. GFP fusion protein constructs. GFP was fused to the
NH2 terminus of full-length or individual domains of syntrophin.
Numbers indicate the amino acid residues of syntrophin, begin-
ning with the initiator methionine. The PH1a and PH1b domains,
normally separated by the PDZ domain, were assembled into a
continuous fusion protein. 
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teraction between syntrophin and utrophin (Fig. 6 A).
Utrophin also coimmunoprecipitated with the PH2SU
tandemly linked domains, but not with PH1PDZ or indi-
vidual syntrophin domains (Fig. 6 A). This ability of the
GFP-PH2SU fusion protein to bind utrophin may underlie
its localization on the basolateral membrane.
A current model of the stoichiometry of the DAPC in
muscle predicts one utrophin, one dystrobrevin, and two
syntrophins per complex: one syntrophin binds directly to
utrophin or dystrophin and another binds to a dystrobre-
vin family member (Fig. 7; Peters et al., 1997a; Sadoulet-
Puccio et al., 1997). To test whether two syntrophins are
present in epithelial syntrophin/utrophin complexes, we
determined whether endogenous syntrophin copurified
with exogenously expressed GFP-syntrophin (Fig. 6 B).
We used an antibody directed against the syntrophin PDZ
domain (SYN1351) to detect endogenous syntrophin in
samples immunoprecipitated with GFP antibodies. Al-
though SYN1351 also detects GFP-FL, GFP-PH1PDZ,
and GFP-PDZ constructs (Fig. 6 B, thin arrows), they are
well separated from the endogenous syntrophin on our im-
munoblots (except in the case of the PH1PDZ construct,
which is the same size as endogenous syntrophin). In these
immunoprecipitation experiments we find that endoge-
nous syntrophin (Fig. 6 B, thick arrow) copurifies with
GFP-FL and GFP-PH2SU, but not with GFP-PH1, GFP-
PDZ, GFP-PH2, or GFP-SU fusion proteins. Although we
cannot determine whether endogenous syntrophin copuri-
fies with GFP-PH1PDZ, we believe it does not since it
fails to copurify utrophin and dystrobrevin. To accommo-
date two syntrophin binding sites, a dystrobrevin must also
be present in the complex. When blots were probed with a
panspecific dystrobrevin antibody, we observed a 65-kD
dystrobrevin isoform in samples immunoprecipitated from
GFP-FL and GFP-PH2SU cell lines (Fig. 6 C). Dystrobre-
vin was not detected when GFP antibody was used to im-
munopurify individual GFP-tagged syntrophin domains or
the PH1PDZ fusion protein. The failure of the PDZ fusion
proteins to associate with endogenous syntrophin suggests
that PDZ homodimerization does not occur with syntro-
phins as it does with other PDZ proteins (Srivastava et al.,
1998; Xu et al., 1998).
 
Discussion
 
In this study, we have characterized an epithelial utrophin-
associated protein complex expressed in MDCK cells. Our
data demonstrate that this complex is restricted to the ba-
solateral cell surface of epithelial cells, and includes 
 
b
 
2-
syntrophin and an isoform of dystrobrevin. We find that
utrophin and dystrobrevin copurify with syntrophin, pro-
viding strong evidence that these proteins are associated in
MDCK cells as they are in other tissues (Kramarcy et al.,
1994; Ahn and Kunkel, 1995; Dwyer and Froehner, 1995;
Yang et al., 1995).
The dystrobrevins are divided into two families, 
 
a
 
 and 
 
b
 
,
which undergo extensive alternative splicing (Blake et al.,
1996, 1998; Sadoulet-Puccio et al., 1996; Peters et al.,
1997b; Puca et al., 1998). The molecular mass of dystrobre-
vin found in MDCK cells is 
 
z
 
65 kD (Figs. 2 and 6 C)
and, thus, could correspond to either 
 
a
 
-dystrobrevin-2 or
 
b
 
-dystrobrevin. Although our isoform-specific antibodies
are not reactive with the canine proteins, therefore pre-
venting a direct test of this question, we believe that this
MDCK protein is likely 
 
b
 
-dystrobrevin for two reasons.
First, 
 
b
 
-dystrobrevin is enriched in epithelial tissues (Pe-
ters et al., 1997b; Blake et al., 1998), while 
 
a
 
-dystrobre-
vin-2 is restricted to brain, skeletal, and cardiac muscle
(Peters et al., 1997b). In addition, 
 
a
 
-dystrobrevin-2 associ-
ates preferentially with dystrophin (Peters et al., 1998), and
Figure 5. Basolateral targeting of
GFP-tagged syntrophin requires the
PH2SU domains. Stable MDCK cell
lines expressing GFP-tagged syntro-
phin fusion proteins were grown to
confluence on glass coverslips and
were analyzed by confocal microscopy.
At least three separate clones were an-
alyzed for each construct, and similar
results were obtained when cells were
grown on transwell filters. Images are
shown as XZ scans. (A) GFP-FL was
restricted to the basolateral mem-
brane, in a pattern indistinguishable
from endogenous syntrophin. (B) The
PH1, PDZ, PH2, and SU fusion pro-
teins remain cytoplasmic and were not
enriched at the basolateral membrane.
(C) While GFP-PH1PDZ remained
cytoplasmic, GFP-PH2SU was re-
stricted to the basolateral membrane,
in a pattern indistinguishable from en-
dogenous syntrophin or GFP-FL. Bar,
10 mm. 
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therefore is unlikely to be found in a utrophin complex.
Taken together, these data suggest that 
 
b
 
-dystrobrevin is
the isoform present in MDCK cells.
While multiple syntrophins are often expressed in the
same tissue, a single isoform often predominates. For in-
stance, 
 
a
 
1-syntrophin is the major form in skeletal and car-
diac muscle, 
 
b
 
1-syntrophin in liver and smooth muscle,
and 
 
b
 
2-syntrophin in epithelial-rich tissues like kidney and
lung (Peters et al., 1997a). In tissues where 
 
b
 
2-syntrophin
is not the dominant form, such as brain and muscle, it is of-
ten restricted to sites of membrane specialization, such as
the neuromuscular junction (Peters et al., 1994, 1997a) and
retinal synapses (Peters, M.F., C. Houlihan, and S.C.
Froehner, unpublished results). Thus, 
 
b
 
2-syntrophin may
play a unique role at membrane specializations. Here, we
find that 
 
b
 
2-syntrophin is the dominant syntrophin iso-
form expressed in MDCK cells. The predominance of 
 
b
 
2-
syntrophin could be explained by the failure of the 
 
a
 
1-syn-
trophin and two 
 
b
 
1-syntrophin isoform specific antibodies
to recognize canine syntrophins. However, the abundance
of 
 
b
 
2-syntrophin in epithelial-rich rodent tissues and in a
human bronchial epithelial cell line (data not shown), in
which our antibodies are known to be reactive, suggests
that 
 
b
 
2-syntrophin is the major isoform in epithelia.
The syntrophin/utrophin complex of MDCK cells prob-
ably includes the dystroglycans. We find 
 
a
 
-dystroglycan
on the basolateral membrane of MDCK cells (data not
shown) consistent with report of dystroglycans on the
basal surface of epithelial cells in vivo (Durbeej et al.,
1998). These data support a model (Fig. 7) in which the
syntrophin/utrophin complex serves as a link between the
ECM and the actin cytoskeleton in epithelia, as it does in
skeletal muscle.
There have been reports of a dystrophin short form,
Dp140, on the basal surface of tubule epithelial cells in
kidney (Durbeej et al., 1997; Lidov and Kunkel, 1998).
While we did detect some dystrophin by immunofluores-
cence in MDCK cells (data not shown), it was not found at
the basolateral membrane. Thus, dystrophin may be im-
portant in certain epithelia, but we do not believe it is part
of the basolateral complex in MDCK cells.
 
Interaction of Syntrophin Domains with Utrophin
 
The region on dystrophin that binds syntrophins has been
mapped to a short segment encoded by exon 74 (and to
homologous regions in utrophin and dystrobrevin; Yang et
al., 1994; Ahn and Kunkel, 1995; Suzuki et al., 1995). How-
ever, identification of the region of syntrophin responsible
for binding to dystrophin family members has not been re-
ported. Binding studies using in vitro translated proteins
showed that a 37-kD fragment containing the COOH ter-
minus of 
 
b
 
1-syntrophin is sufficient for association with
dystrophin family members (Ahn and Kunkel, 1995). We
find that individual PH2 or SU domains fail to bind utro-
phin, but when these domains are tandemly linked (as they
are in the native protein) binding to utrophin is restored.
These data suggest that the combined PH2 and SU do-
mains function as a unit. Perhaps the binding site for utro-
phin is formed by noncontiguous partial binding sites in
the PH2 and SU domains. Alternatively, the region of syn-
trophin responsible for binding utrophin may bridge se-
quences in the PH2 and SU domains. Although the indi-
vidual constructs used for expression of PH2 and SU
domains overlapped by four amino acids, it is possible that
proper folding of this bridge region requires a longer
polypeptide. Finally, it is possible that the utrophin bind-
ing site is contained within a single domain, but that both
domains are required for proper folding of the interacting
site. While our data do not discriminate between these
possibilities, they do provide in vivo evidence that an in-
tact PH2SU domain is necessary and sufficient for syntro-
phin binding to utrophin.
 
Two Syntrophins per Complex
 
In muscle, the current model of the DAPC includes dys-
trophin or utrophin directly associated with a dystrobrevin
family member through a coiled-coil interaction (Peters et
al., 1997a; Sadoulet-Puccio et al., 1997). The presence of
Figure 6. Interaction of syntrophin domains with utrophin and
dystrobrevin. Triton X-100 soluble extracts from transfected cell
lines were incubated with either a polyclonal GFP antibody or
control rabbit IgG. Immunoprecipitated proteins were immuno-
blotted with specific antibodies. (A) GFP-tagged syntrophin con-
structs, revealed by immunoblotting with a GFP mAb, are the ex-
pected sizes and are present in approximately equal amounts.
Utrophin was coimmunoprecipitated with GFP-FL and GFP-
PH2SU fusion proteins, but not with individual domains. (B) En-
dogenous syntrophin (thick arrow) was coimmunoprecipitated
with GFP-FL and GFP-PH2SU only. Since the epitope recog-
nized by the syntrophin antibody SYN1351 is in the PDZ domain
of syntrophin, GFP-FL, GFP-PH1PDZ, and GFP-PDZ fusion
proteins were also labeled (thin arrows). GFP-PH1PDZ comi-
grates with syntrophin, precluding any conclusions regarding the
copurification of endogenous syntrophin with this construct. (C)
A 65-kD dystrobrevin isoform was coimmunoprecipitated with
GFP-FL and GFP-PH2SU, but not with individual domains or
PH1PDZ. Positions of molecular mass markers are shown in kD
on the right. 
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syntrophin binding sites in both dystrophin or utrophin,
and dystrobrevin allows for the binding of two syntrophins
per complex (Fig. 7). Support for this model comes from
the demonstration that dystrophin or utrophin complexes
contain pairs of syntrophin isoforms (Peters et al., 1997a)
and a stoichiometry of two syntrophins per complex
(Yoshida and Ozawa, 1990; Ervasti and Campbell, 1991).
In this study, we tested the hypothesis that two syntro-
phins are contained within the epithelial syntrophin/
utrophin complex by expressing GFP-tagged syntrophin
(GFP-FL) in MDCK cells. In experiments in which GFP-
tagged syntrophin was immunoprecipitated with anti-
GFP, we detected not only utrophin and dystrobrevin, but
also endogenous syntrophin. A single syntrophin binding
site on utrophin and dystrobrevin likely accounts for the
two syntrophins in the purified complex. The amount of
endogenous syntrophin is approximately half that of the
GFP-tagged syntrophin, suggesting that some purified
complexes contain two GFP-tagged syntrophins, while
others contain one GFP-tagged syntrophin and one en-
dogenous syntrophin. Whether GFP-tagged syntrophin
displaces endogenous syntrophin or instead binds to unoc-
cupied sites on utrophin and dystrobrevin is unclear. Al-
ternatively, our results could also be explained by di-
merization of syntrophins within the complex. Although
evidence for syntrophin dimerization has been reported
(Yang et al., 1994; Madhavan and Jarrett, 1995), alterna-
tive explanations for these findings have been suggested
(Ahn et al., 1996; Peters et al., 1997). Our data indicate
that if syntrophin dimerization does occur, it must be via
the PH2 and SU domains, since none of the other con-
structs were able to copurify endogenous syntrophin.
 
Targeting of the Syntrophin/Utrophin Complex in 
Polarized Epithelia
 
Epithelial cells contain distinct apical and basolateral cell
surfaces with unique protein and lipid compositions (Si-
mon and Fuller, 1985; Rodriguez-Boulan and Nelson,
1989). The epithelial syntrophin/utrophin complex is re-
stricted to the basolateral cell surface. As a first step in un-
derstanding the sorting of the syntrophin/utrophin com-
plex to the basolateral membrane of epithelial cells, we
investigated the targeting of syntrophin in MDCK cells.
Our results show that the tandemly linked PH2 and SU
domains are necessary and sufficient for directing GFP-
tagged syntrophin to the basolateral membrane (Fig. 5
C). The PH domain and additional COOH-terminal se-
quences are also required to target cytohesion-1 and Bru-
ton’s tyrosine kinase to the plasma membrane (Nagel et
al., 1998). However, it is not simply the presence of a PH
domain which confers membrane targeting of syntrophin
since the PH1PDZ construct failed to accumulate at the
basolateral membrane. Interestingly, replacement of the
cytohesion-1 PH domain with the PH domain of the 
 
b
 
1-
adrenergic receptor abolished membrane targeting (Nagel
et al., 1998).
The amino acid residues responsible for targeting syn-
trophin to the basolateral membrane may also be neces-
sary for binding to utrophin. Alternatively, syntrophin
may contain two independent regions, one responsible for
binding to utrophin and a second involved in binding
structures at the basolateral membrane. Site-directed mu-
tagenesis of the PH2SU domain may allow for the discrim-
ination of utrophin-binding and basolateral targeting func-
tions within this region of syntrophin.
In epithelia, the signals responsible for polarized sorting
are best characterized for transmembrane proteins. For in-
stance, several integral membrane proteins that target to
the basolateral surface in epithelial cells contain di-leucine
or tyrosine-based basolateral sorting sequences (Ktistakis
et al., 1990; Thomas et al., 1993; Hunziker and Fumey,
1994; Matter et al., 1994; Sheikh and Isacke, 1996; Simon-
sen et al., 1998). Therefore, we examined the sequence
of 
 
b
 
-dystroglycan for potential targeting sequences and
found a conserved sequence, EDQATFI (amino acids
784–790 in mouse and human) in the COOH terminus
of 
 
b-dystroglycan, that is very similar to the consensus
sequence for the di-leucine basolateral sorting motif,
DDQxxLI (Matter et al., 1994; Simonsen et al., 1998). In
b-dystroglycan, this motif is predicted to be cytoplasmic
and does not overlap with the dystrophin binding site
Figure 7. Hypothetical model of
the syntrophin/utrophin com-
plex in MDCK cells. Utrophin
binds cytoskeletal actin through
its NH2-terminal domain and is
linked to laminin in the ECM
via  a- and b-dystroglycans.
Utrophin and dystrobrevin asso-
ciate through coiled-coil interac-
tions (H1 and H2). Syntrophin
binding sites on utrophin and
dystrobrevin recruit two syntro-
phins to the complex. The inter-
action of syntrophin with utro-
phin and dystrobrevin occurs via
the PH2 and SU domains of syn-
trophin, leaving the PH1 and
PDZ domains free to bind addi-
tional proteins.Kachinsky et al. Syntrophin/Utrophin Complex in Epithelial Cells 399
(Jung et al., 1995). The cytoplasmic targeting motifs found
in basolateral proteins are often followed by small clusters
of acidic residues (Matter et al., 1994). The presence of the
sequence DELDD downstream of the putative di-leucine
motif in b-dystroglycan supports a role for this motif in ba-
solateral sorting. It will be interesting to examine the im-
portance of this sequence in the targeting of b-dystrogly-
can and other components of the syntrophin/utrophin
complex in epithelial cells.
Role of Syntrophin/Utrophin Complex in Epithelia
At this time, we can only speculate as to the function of
the basolateral syntrophin/utrophin complex in polarized
epithelia. The syntrophin/utrophin complex, through its
ability to link ECM proteins to actin, may serve a struc-
tural role in epithelia. In skeletal muscle, the link between
the ECM and the cytoskeleton is thought to maintain cell
membrane integrity during contraction (Petrof et al., 1993;
Pasternak et al., 1995). Some epithelia must also withstand
the forces of contraction (i.e., in the gastrointestinal tract).
Thus, a link between the ECM and actin provided by the
syntrophin/utrophin complex, may maintain membrane in-
tegrity in epithelia. The syndecan/CASK complex also
links the ECM to the actin cytoskeleton (Cohen et al.,
1998), and may play a role similar to the syntrophin/utro-
phin complex in epithelia.
The syntrophin/utrophin complex may also function to
recruit proteins to the basolateral surface of epithelial
cells. Syntrophins are modular adapter proteins made up
almost exclusively of protein–protein interaction domains
(Ahn et al., 1994, 1996; Adams et al., 1995). Our results in-
dicate that the PH1 and PDZ domains do not play a role in
targeting syntrophin to the basolateral membrane. In con-
trast, the PDZ domains of Dlg/SAP97 are necessary for ef-
ficient subcellular targeting (Lue et al., 1996; Hough et al.,
1997; Wu et al., 1998), indicating that modular adapter
proteins may be targeted via different mechanisms. The
PH1 and PDZ domains of syntrophin are also unnecessary
for the interaction of syntrophin with utrophin. Therefore,
these domains are free to interact with additional proteins
to generate a large multiprotein complex (Fig. 7). Binding
partners for the PH1 domain of syntrophin have not been
identified, but PH domains in other proteins are capable
of binding proteins such as protein kinase C, and the b and
g subunits of G proteins (Touhara et al., 1994; Yao et al.,
1994).
The ability of the PDZ domain of syntrophin to bind
nNOS in muscle (Brenman et al., 1996) suggests that one
function of syntrophin is to recruit signaling proteins to
the membrane. Interestingly, the presence of two syntro-
phins per complex (Fig. 7) may allow two different pro-
teins to be brought in close apposition, allowing for one to
modulate the other. For instance, in skeletal muscle, syn-
trophin PDZ domains also bind voltage-gated sodium
channels (Brenman et al., 1996; Gee et al., 1998; Schultz et
al., 1998). NO modulates the activity of certain sodium
channels (Li et al., 1998), a process that may occur with
high efficiency and specificity if nNOS and sodium chan-
nels reside in the same complex. The recruitment of two
proteins into the DAPC in muscle has potential functional
consequences: the formation of similar complexes contain-
ing signaling molecules, and effector proteins may also oc-
cur in epithelia. Thus, it will be important to identify bind-
ing partners for the PH1 and PDZ domains to gain further
understanding of the function of the syntrophin/utrophin
complex in epithelia.
PDZ domain-containing proteins are a common feature
of many scaffolding complexes (Cho et al., 1992; Kornau
et al., 1995; Kim et al., 1996; Dong et al., 1997; Cohen et
al., 1998; Short et al., 1998; Srivastava et al., 1998; Xu et al.,
1998). Through their interactions with the COOH-termi-
nal tails of receptors and ion channels, PDZ domains are
critical in the assembly of multiprotein complexes. Many
scaffolding proteins contain multiple PDZ domains, which
may tether multiple copies of the same ligand at a particu-
lar subcellular location. More often, the PDZ domains
within a single protein have distinct binding specificities,
allowing different proteins to be recruited to the same sub-
cellular location. An elegant illustration of the efficiency
of such complexes comes from studies of INAD (inactiva-
tion no after potential D) where a single type of scaffold
links all (or most) proteins needed for Drosophila pho-
totransduction (reviewed in Montell, 1998). Interestingly,
homodimerization of INAD molecules generates a com-
plicated network of proteins at the membrane (Xu et al.,
1998). Furthermore, the potential for homodimerization
of proteins which contain 6–13 PDZ domains (Dong et al.,
1997; Srivastava et al., 1998; Ullmer et al., 1998), raises the
complexity of scaffolding complexes to almost incompre-
hensible heights.
In epithelia, the asymmetric localization of proteins and
lipids results in functional differences between the apical
and basolateral membranes required for epithelial cell
function. MDCK cells sort secretory and membrane-asso-
ciated proteins to apical and basolateral surfaces by sev-
eral different mechanisms (reviewed in Simons and Wand-
inger-Ness, 1990; Caplan, 1997). Some proteins are packaged
upon exit from the TGN into separate apical or basolat-
eral transport vesicles (Wadinger-Ness et al., 1990). Other
proteins are targeted exclusively to the basolateral domain
but do not remain there; instead they are internalized into
endosomes and targeted via the transcytotic pathway to
the apical cell surface. Finally, some proteins are trans-
ported in a nonpolarized manner to both cell surfaces, but
are selectively stabilized at one surface. For example, the
Na/K ATPase is stabilized at the basolateral cell surface
by association with the actin cytoskeleton and ankyrin
(Nelson and Veshnock, 1987; Jordan et al., 1995; The-
vananther et al., 1997). Syntrophin may play a similar role
and act to specifically anchor transmembrane proteins by
high affinity protein–protein interactions via the PDZ or
PH domains. However, since PDZ proteins are present on
both apical and basolateral cell surfaces, and at the TJs,
additional factors that define binding specificities must be
involved.
In addition to a targeting role once a polarized mono-
layer is formed, the epithelial syntrophin/utrophin com-
plex may be involved in the development of polarity in ep-
ithelial cells. Drubin and Nelson (1996) proposed that
extracellular cues, such as cell–cell adhesion, define dis-
crete areas of membrane as sites of submembranous cy-
toskeletal assembly. Once assembled, the cytoskeleton
serves as a docking site for specific proteins, leading to fur-The Journal of Cell Biology, Volume 145, 1999 400
ther specialization of this region of membrane. In MDCK
cells, E-cadherin–mediated adhesion defines the site for
recruitment of the sec6/sec8 complex (Grindstaff et al.,
1998). This protein complex then serves as a docking site
for additional proteins. By serving as a link between the
ECM and the submembranous cytoskeleton, the syntro-
phin/utrophin complex may also assist in defining basal
membranes during morphogenesis. Laminin, a component
of the basement membrane which binds dystroglycan
(Ibraghimov-Beskrovnaya et al., 1992; Gee et al., 1993),
plays an important role in the differentiation of epithelia
in vivo and in vitro (Klein et al., 1988; Ekblom et al., 1990;
Durbeej et al., 1995). Antibodies that block the binding of
laminin to dystroglycan in organ cultures inhibit epithelial
differentiation (Durbeej et al., 1995). Perhaps the binding
of laminin serves to recruit the syntrophin/utrophin com-
plex to the basal membrane, where it participates in the
specialization of this cell surface. In addition, the heparan
sulfate proteoglycan, agrin, is found in the basement mem-
brane of epithelial tissues, where it binds dystroglycan
(Gesemann et al., 1998; Raats et al., 1998). It is important
to note that antibodies that disrupt the laminin–dystrogly-
can interaction may also block agrin binding (Ervasti and
Campbell, 1993; Campanelli et al., 1994; Gee et al., 1994),
suggesting that agrin may also be involved in epithelial
morphogenesis via the syntrophin/utrophin complex. The
use of additional cell culture model systems and transgenic
or knockout animals will help in defining functions for the
epithelial syntrophin/utrophin complex.
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